The Role of Nocturnin in Early Adipogenesis and Modulation of Systemic Insulin Resistance in Human

The deadenylase nocturnin (Noc, Ccrn4l) has been recently found to regulate lipid metabolism and to control preadipocyte differentiation. Here, we showed that among the five deadenylases tested, Noc and Pan2 exhibited a biphasic expression which is out of phase to each other during adipocyte differe...

Full description

Saved in:
Bibliographic Details
Published inObesity (Silver Spring, Md.) Vol. 20; no. 8; pp. 1558 - 1565
Main Authors Hee, Siow‐Wey, Tsai, Shu‐Huei, Chang, Yi‐Cheng, Chang, Ching‐Jin, Yu, I‐Shing, Lee, Po‐Chu, Lee, Wei‐Jei, Chang, Yun‐Chia Emily, Chuang, Lee‐Ming
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.08.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The deadenylase nocturnin (Noc, Ccrn4l) has been recently found to regulate lipid metabolism and to control preadipocyte differentiation. Here, we showed that among the five deadenylases tested, Noc and Pan2 exhibited a biphasic expression which is out of phase to each other during adipocyte differentiation of 3T3‐L1 cells. The expression levels of other deadenylases, including Parn, Ccr4, and Caf1, were relatively unchanged or reduced. The immediate early expressed Noc during 3T3‐L1 adipogenesis was involved in regulating mitotic clonal expansion (MCE) and cyclin D1 expression, as demonstrated in Noc‐silenced 3T3‐L1 cells and Noc−/− primary mouse embryonic fibroblasts (MEFs). Transcriptional profiling of Noc‐depleted 3T3‐L1 adipocytes revealed that most of the differentially expressed genes were related to cell growth and proliferation. In human adipose tissue, NOC mRNA level negatively associated with both fasting serum insulin and homeostasis model assessment of insulin resistance, and positively associated with both adiponectin mRNA levels and circulating adiponectin levels. Taken together, these results suggest the role of Noc in the modulation of early adipogenesis as well as systemic insulin sensitivity.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:1930-7381
1930-739X
1930-739X
DOI:10.1038/oby.2012.37